Lack of Effects of Renin-Angiotensin-Aldosterone System Activity and Beta-Adrenoceptor Pathway Polymorphisms on the Response to Bisoprolol in Hypertension

MLA

Weiwei Zeng, et al. “Lack of Effects of Renin-Angiotensin-Aldosterone System Activity and Beta-Adrenoceptor Pathway Polymorphisms on the Response to Bisoprolol in Hypertension.” Frontiers in Cardiovascular Medicine, vol. 9, Apr. 2022. EBSCOhost, https://doi.org/10.3389/fcvm.2022.842875.

APA

Weiwei Zeng, Tanya T. W. Chu, Chung Shun Ho, Clara W. S. Lo, Alan S. L. Chan, Alice P. S. Kong, Brian Tomlinson, & Sze Wa Chan. (2022). Lack of Effects of Renin-Angiotensin-Aldosterone System Activity and Beta-Adrenoceptor Pathway Polymorphisms on the Response to Bisoprolol in Hypertension. Frontiers in Cardiovascular Medicine, 9. https://doi.org/10.3389/fcvm.2022.842875

Chicago

Weiwei Zeng, Tanya T. W. Chu, Chung Shun Ho, Clara W. S. Lo, Alan S. L. Chan, Alice P. S. Kong, Brian Tomlinson, and Sze Wa Chan. 2022. “Lack of Effects of Renin-Angiotensin-Aldosterone System Activity and Beta-Adrenoceptor Pathway Polymorphisms on the Response to Bisoprolol in Hypertension.” Frontiers in Cardiovascular Medicine 9 (April). doi:10.3389/fcvm.2022.842875.